Apogee Therapeutics Files 2024 10-K
Ticker: APGE · Form: 10-K · Filed: Mar 3, 2025 · CIK: 1974640
| Field | Detail |
|---|---|
| Company | Apogee Therapeutics, Inc. (APGE) |
| Form Type | 10-K |
| Filed Date | Mar 3, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, biotechnology, financials
Related Tickers: APGE
TL;DR
APGE filed its 2024 10-K. Full financials and biz details inside.
AI Summary
Apogee Therapeutics, Inc. filed its 2024 10-K on March 3, 2025, reporting its fiscal year ending December 31, 2024. The company, focused on biological products, is based in Waltham, MA. Key financial data and operational details for the period are outlined in this comprehensive filing.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of Apogee Therapeutics' financial health, business operations, and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a biotechnology company, Apogee Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period covered by the 10-K)
- 2025-03-03 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Apogee Therapeutics, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-03 (date) — Filing date
- Waltham, MA (location) — Company headquarters
- 2836 (industry_code) — Standard Industrial Classification for Biological Products
- 001-41740 (sec_file_number) — SEC file number for Apogee Therapeutics
- Paragon Therapeutics, Inc. (company) — Mentioned in relation to a license agreement
- 2023-07-18 (date) — Date related to IPO
FAQ
What is Apogee Therapeutics' primary business focus?
Apogee Therapeutics, Inc. is focused on Biological Products (NO DIAGNOSTIC SUBSTANCES), as indicated by its SIC code 2836.
When did Apogee Therapeutics change its name from Apogee Therapeutics, LLC?
The company changed its name from Apogee Therapeutics, LLC on 20230420.
What is the SEC file number for Apogee Therapeutics?
The SEC file number for Apogee Therapeutics is 001-41740.
What is the business address of Apogee Therapeutics?
The business address for Apogee Therapeutics is 221 Crescent St., Building 17, Suite 102B, Waltham, MA 02453.
What is the significance of the date 2023-07-18 in the filing?
The date 2023-07-18 is associated with the company's IPO (Initial Public Offering).
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 3, 2025 regarding Apogee Therapeutics, Inc. (APGE).